Elizabeth Schneider: Revolutionary Drug Shows Promise for Primary Ovarian Insufficiency
Elizabeth Schneider, Staff Product Marketing Manager at Illumina, shared a post on LinkedIn:
“Primary ovarian insufficiency (POI), in which the ovaries don’t mature and release eggs properly, affects about 3% of women under age 40 and typically causes infertility. But a drug already approved to treat kidney disease may one day help some of these people get pregnant, a research team reports today in Science.
In studies of mouse ovarian tissue and live mice, the drug, called finerenone, kick-started the growth of tiny egg-containing sacs, or follicles—a process that’s often defunct in people with POI. In a small clinical trial, people with POI who were given the drug went on to produce mature eggs that could be harvested, and some of the eggs were then successfully fertilized in the lab.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Sep 4, 2026, 17:17Dan Annetts: The Fabulous CREATE Fertility Bristol Team This Week
-
Sep 4, 2026, 17:15Arsiak Vartenian: The Question I Wish Fertility Clinics Asked Women More…
-
Sep 4, 2026, 17:13Zeynab Kazemianpour: 2 Unusual Oocytes Observed Before ICSI
-
Sep 4, 2026, 17:11Saff Mitten: Do You Ever Worry Your Friends Are Getting Bored of Your Long IVF Journey?
-
Sep 4, 2026, 17:04David Pening: New Article on the Genetic Landscape of Acephalic Spermatozoa Syndrome
-
Sep 4, 2026, 16:55Blessed Obediran: The Science of Donor Conception Is Easy, The Harder Questions Are the Ethical Ones
-
Sep 4, 2026, 16:51Delighted to Welcome a Team of Colleagues from St. Gallen, Switzerland – Brussels IVF
-
Sep 4, 2026, 16:48Vikrant Bhatia: In Fertility Care, More Information Doesn’t Always Mean Better Decisions
-
Sep 4, 2026, 16:46Priyadatt Patel: Few Numbers Cause as Much Unnecessary Distress as AMH